Clarus Wealth Advisors »

Neurocrine Biosciences shares owned by Clarus Wealth Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Clarus Wealth Advisors from 13F filings

Historical chart of Clarus Wealth Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Clarus Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Clarus Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $206k 1.5k 138.09
2023-12-31 $252k 1.8k 136.75
2019-06-30 $68k 802 84.79
2019-03-31 $17k 194 87.63
2018-12-31 $14k 194 72.16
2018-09-30 $12k 97 123.71

More positions owned by Clarus Wealth Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard World Mega Grwth Ind (MGK)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Apple (AAPL)
Pacer Fds Tr Emrg Mkt Cash (ECOW)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p Mcp Etf (IJH)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Growth Etf (VUG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)

View all positions for Clarus Wealth Advisors

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences